HPGD
15-hydroxyprostaglandin dehydrogenase | SDR36C1

This gene encodes a member of the short-chain nonmetalloenzyme alcohol dehydrogenase protein family. The encoded enzyme is responsible for the metabolism of prostaglandins, which function in a variety of physiologic and cellular processes such as inflammation. Mutations in this gene result in primary autosomal recessive hypertrophic osteoarthropathy and cranioosteoarthropathy. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]

Developmental clusters: GC3
Biological processes 45 terms
15-hydroxyicosatetraenoate dehydrogenase activity (GO:0047034)15-hydroxyprostaglandin dehydrogenase (NAD+) activity (GO:0016404)15-hydroxyprostaglandin dehydrogenase (NAD+) activity (GO:0016404)15-hydroxyprostaglandin dehydrogenase (NAD+) activity (GO:0016404)15-hydroxyprostaglandin dehydrogenase (NAD+) activity (GO:0016404)15-hydroxyprostaglandin dehydrogenase (NAD+) activity (GO:0016404)NAD binding (GO:0051287)NAD+ binding (GO:0070403)basolateral plasma membrane (GO:0016323)cytoplasm (GO:0005737)cytoplasm (GO:0005737)cytosol (GO:0005829)cytosol (GO:0005829)cytosol (GO:0005829)ductus arteriosus closure (GO:0097070)ductus arteriosus closure (GO:0097070)extracellular exosome (GO:0070062)extracellular region (GO:0005576)female pregnancy (GO:0007565)female pregnancy (GO:0007565)female pregnancy (GO:0007565)identical protein binding (GO:0042802)identical protein binding (GO:0042802)kidney development (GO:0001822)lipoxin biosynthetic process (GO:2001301)lipoxygenase pathway (GO:0019372)negative regulation of cell cycle (GO:0045786)ovulation (GO:0030728)oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)parturition (GO:0007567)positive regulation of apoptotic process (GO:0043065)positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707)prostaglandin E receptor activity (GO:0004957)prostaglandin catabolic process (GO:1905344)prostaglandin metabolic process (GO:0006693)prostaglandin metabolic process (GO:0006693)prostaglandin metabolic process (GO:0006693)regulation of prostaglandin catabolic process (GO:1905828)response to estradiol (GO:0032355)response to ethanol (GO:0045471)response to lipopolysaccharide (GO:0032496)thrombin-activated receptor signaling pathway (GO:0070493)thrombin-activated receptor signaling pathway (GO:0070493)transforming growth factor beta receptor signaling pathway (GO:0007179)
Expression (TPM)
HPGD — as a Regulated Gene

TFs regulating HPGD 0 TFs

Transcription factors with Perturb-seq knockdown data for HPGD. The Binding column indicates whether any binding evidence exists for this TF–gene pair (ChIP-seq or motif footprint peaks). The Mean coef is the average Perturb-seq regression coefficient across active gRNAs (positive = HPGD upregulated upon KD; negative = downregulated). The Outlier column indicates whether this gene is in the top or bottom 5% of all TF knockdown effects.

Data: Effect:
TF Mean coef Binding Outlier TF→Gene link

Elements linked to HPGD

Open chromatin peaks (ATAC-seq) in the genomic neighbourhood of HPGD, linked by TSS proximity or chromatin conformation (Multiome / HiCAR). Each element overlaps at least one TF ChIP-seq binding site — the TFs column shows how many distinct TFs bind that element.

Accessibility Element Dist. to TSS Link type TFs
chr4:174,519,256–174,519,828 2.8 kb Proximal (<10kb) 8
chr4:174,521,789–174,523,574 at TSS At TSS 565
chr4:174,531,709–174,532,360 9.1 kb Proximal (<10kb) 54

Genome Browser

Genomic view of the HPGD locus showing ATAC-seq accessibility and RNA-seq expression across the ESC → DE time course, together with TF binding peaks and element-to-TSS loop connections.

chr4:174,509,256 – 174,542,360
Proximal 1 kb Distal 10 kb Multiome HiCAR ATAC-seq RNA-seq